Please use this identifier to cite or link to this item:
Type: Journal article
Title: Doxorubicin overcomes resistance to drozitumab by antagonizing inhibitor of apoptosis proteins (IAPS)
Author: Zinonos, I.
Labrinidis, A.
Liapis, V.
Hay, S.
Panagopoulos, V.
Denichilo, M.
Ponomarev, V.
Ingman, W.
Atkins, G.
Findlay, D.
Zannettino, A.
Evdokiou, A.
Citation: Anticancer Research: international journal of cancer research and treatment, 2014; 34(12):7007-7020
Publisher: International Institute of Anticancer Research
Issue Date: 2014
ISSN: 0250-7005
Statement of
Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, Shelley Hay, Vasilios Panagopoulos, Mark Denichilo, Vladimer Ponomarev, Wendy Ingman, Gerald J. Atkins, David M. Findlay, Andrew C. W. Zannettino and Andreas Evdokiou
Abstract: Background/Aim: Drozitumab is a fully human agonistic monoclonal antibody that binds to death receptor DR5 and induces apoptosis. However, drozitumab resistance is a major obstacle limiting anticancer efficacy. Materials and Methods: We examined the potential for the chemotherapeutic agent doxorubicin to overcome resistance against drozitumab-resistant breast cancer cells both in vitro and in vivo. Results: Treatment with doxorubicin increased cell surface expression of DR5, reduced levels of Inhibitors of Apoptosis Proteins (cIAPs) and re-sensitised cells to drozitumab-induced apoptosis. Animals implanted with resistant breast cancer cells into the mammary fat pad and treated with a combination of drozitumab and doxorubicin showed inhibition of tumor growth and a substantial delay in tumor progression compared to untreated controls and mice treated with each agent alone. Conclusion: These results suggest that combination of drozitumab with chemotherapy and agents that modulate IAP levels could potentially be a useful strategy in the treatment of breast cancer.
Keywords: Apoptosis; Apo2L/TRAIL; drozitumab; drug resistance; chemotherapy; breast cancer
Rights: Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Grant ID:
Published version:
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.